Sanderling Ventures
Venture capitalSan Mateo · Seed–Late Stage · 8 people tracked
Also known as SANDERLING MANAGEMENT COMPANY, LLC
Investment thesis
Sanderling invests in and helps build biomedical companies, combining a specialized investment focus with active management and a long-term commitment. The firm emphasizes close working partnerships with entrepreneurs to build significant companies and generate strong returns for both founders and investors. Areas of specialization include small molecule therapeutics, biologics and vaccines, drug delivery, platform technologies, and medical devices.
Source: firm website, verified Aug 25, 2026.
Team · 8 people
from the firm's website
What they invest in
from 40 of 73 portfolio companiesHealthtech ×28Biotech ×26Medical Devices ×19Digital Health ×3Hardware ×3Deep Tech ×2Advanced Manufacturing ×1AI & Machine Learning ×1
HQs:United States×23Belgium×1Germany×1France×1Netherlands×1
Investments · 73 tracked
founders shown can be your intro pathBy year:2023 · 12020 · 22019 · 12017 · 22016 · 12015 · 12012 · 19 dated
HCW Biologics is a clinical-stage biopharmaceutical company developing fusion immunotherapeutics as first-in-class immunotherapies for autoimmune diseases, cancer, and senescence-associated dysplasia.
BiotechHealthtechLongevityMiramar, US
Hing C Wong(Executive Officer, Director)Hing C. Wong(Founder & CEO)Hing W.(Founder)inLee Flowers(Executive Officer)Rebecca Byam(Executive Officer)Peter Rhode(Executive Officer)
Board seatFred Middleton· per SEC Form D · $16M raise · filed Oct 2020
Boston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
HealthtechMedical Devices
Lance Batesin
Co-investorsAndera PartnersCouncilExcelestar VenturesGood Growth CapitalLongitude CapitalNew Enterprise Associates (NEA)+3 more
BiotechLa Jolla, US
Eric W. Roberts(Executive Officer, Director)Kenneth A. Stauderman(Executive Officer)Daniel Geffken(Executive Officer)A. Rachel Leheny(Executive Officer, Director)Sudarshan Hebbar(Executive Officer)Michael J. Dunn(Executive Officer)
St.Louis, US
David L. Fischel(Executive Officer, Director)Kimberly R. Peery(Executive Officer, Director)David Fischel(Director)Paul A. Brathwaite(Vice President, Research and Development.)Martin C Stammer(Chief Financial Officer.)David A Giffin(Vice President, Human Resources.)
Co-investorsSupernova Invest
Artielle Immunotherapeutics develops DRhQ, a therapeutic platform that targets the CD74 receptor and inhibits macrophage migration inhibitory factor (MIF) to treat neuroinflammatory conditions such as progressive multiple sclerosis and advanced cancers.
BiotechDeep TechHealthtechPortland, US
Renee Shirley(Founder)
BiotechLa Jolla, US
Michael Dunn(Executive Officer, Director)Ken Stauderman(Executive Officer)Daniel Geffken(Executive Officer)Sudarshan Hebbar(Executive Officer)Eric W. Roberts(Executive Officer)Kenneth A. Stauderman(Executive Officer)
Board seatFred MiddletonRobert G. McNeil· per SEC Form D · $17.2M raise · filed May 2020
HealthtechSan Diego, US
Thomas Watlington(Executive Officer, Director)Mark Spring(Executive Officer)
BoardBobby Kandaswamy(Director)Timothy Wollaeger(Director)Kenneth Buechler(Director)Walter Lim(Director)
Board seatRobert G. McNeil· per SEC Form D
Co-investorsForesite CapitalIntel CapitalQualcomm Ventures
Co-investorsAvalon BioVenturesLifeX Ventures
BiotechMiramar, US
Hing C Wong(Executive Officer, Director)Peter Rhode(Executive Officer)
BoardAdam Waldman(Director)Fred Middleton(Director)C. Boyder Gray(Director)
Co-investorsOberland Capital
San Diego, US
Linda Pinney(Executive Officer, Director)Patrick Molino(Executive Officer)Martin Bridges(Executive Officer)
BoardTimothy J. Wollaeger(Executive Officer, Director)Robert G. McNeil(Director)
Asteres builds ScriptCenter automated kiosks and lockers that let patients pick up pharmacist-filled prescriptions and healthcare products securely at any hour, while pharmacy staff retain control over filling and checking.
Digital HealthHardwareHealthtechMedical Devices
Linda Pinney(Founder)inDavid J. Lenny(President & CEO)
CalciMedica is a clinical-stage biopharmaceutical company developing CRAC (calcium release-activated calcium) channel inhibition therapies for serious acute and chronic inflammatory, immunologic, and cardiopulmonary diseases.
BiotechHealthtech
Kenneth A. Stauderman(Co-founder)Gonul Velicelebi(Co-founder)Stephen Bardin(Chief Financial Officer)Sudarshan Hebbar(Chief Medical Officer)Andrew Cunningham(Executive)
BoardEric W. Roberts(Chairman of the Board)
Co-investorsAisling Capital
Philips provides cardiac monitoring and diagnostic solutions that connect patient monitoring across hospital and home settings.
Digital HealthHealthtechMedical Devices
Co-investorsOak Investment Partners
Chimerix is a biopharmaceutical company developing therapies for rare diseases and cancers, with a focus on advancing treatments through biomarker-driven approaches and precision medicine.
BiotechHealthtechMedical DevicesDurham, US
Mike Sherman(Chief Executive Officer and President)Ronald C. Renaud, Jr(Director)W. Garrett Nichols(Chief Medical Officer)Michael A. Alrutz(Executive Officer)Randall Lanier(Chief Science Officer)Roy W. Ware(Chief Manufacturing and Technology Officer)
Co-investorsAisling CapitalAlta PartnersAsset Management CompanyCanaan PartnersFrazier Life SciencesPappas Capital
DalCor Pharmaceuticals is a biopharmaceutical company developing dalcetrapib, a pharmacogenetic precision medicine for cardiovascular disease that targets patients with the ADCY9 AA genotype.
BiotechDeep TechDigital Health
Fouzia Laghrissi-Thode(Chief Executive Officer)Michael Dixon(Chief Financial Officer)Therese Heinonen(Chief Development Officer)Diane Sullivan(Chief Commercial Officer)
Dendreon develops and manufactures cellular immunotherapies, including PROVENGE (sipuleucel-T), an FDA-approved cellular immunotherapy for prostate cancer patients.
BiotechHealthtech
William Amickin
Co-investorsRho Capital PartnersRho Ventures
Skyepharma is a contract development and manufacturing organization (CDMO) specializing in classic and complex oral solid dosage forms, offering product development, manufacturing, and packaging services.
Advanced ManufacturingBiotechHealthtechMedical DevicesFrance, FR
Sébastien Mas(CEO)inNicolas Bedel(Chief Business Officer)inLudivine Laugerette(Quality Director & Qualified Person Site)inChahrazed Derbal(Manufacturing Director)inVirginie Mattens(Head of Human Resources)in
DePuy Synthes develops orthopedic medical devices and solutions including joint reconstruction, trauma, extremities, craniomaxillofacial, spinal surgery, and sports medicine products, along with digital surgery technologies.
HealthtechMedical Devices
Suwanee, US
Matthew G. Molchan(Executive Officer, Director)David Noble(Executive Officer)John W. Sayward(Director)Michael A. Cunnion(Director)Dimitrios J. Angelis(Director)John M. Climaco(Director)
Digirad manufactures portable nuclear medicine imaging cameras for cardiology and general nuclear imaging applications.
HardwareMedical Devices
Dynavax is a commercial-stage biopharmaceutical company that develops and commercializes vaccines against infectious diseases using its adjuvant technology.
BiotechHealthtechDüsseldorf, DE
Ryan Spencer(Chief Executive Officer)David Novack(President and Chief Operating Officer)Robert Janssen(Chief Medical Officer and Senior Vice President, Clinical Development)Kelly MacDonald(Chief Financial Officer)Jeff Coon(Chief Human Resources Officer)Donn Casale(Chief Commercial Officer)
Ethicon develops surgical products and technologies including wound closure, hemostats, surgical stapling, surgical energy, antimicrobial dressings, and surgical instruments, along with clinical education programs for surgeons.
HealthtechMedical Devices
Co-investorsCalifornia Technology Ventures
Developing therapies for congenital disorders of glycosylation combining replacement therapies with intracellular delivery vehicles.
BiotechSan Francisco, US
Christopher Starr(Director)Peter C.M. McWilliams(Director)Agnes Rafalko(Executive Officer, Director)
BoardGiacomo Chiesi(Director)
Co-investorsAdvent Life SciencesChiesi VenturesCTI Life Sciences Fund L.P.Remiges Ventures, Inc.RiverVest Venture PartnersSanofi Ventures
Glycomine develops therapeutics for rare diseases, many of which currently lack disease-modifying treatment options.
Biotech
Steven Axon(Chief Executive Officer)Hicham Alaoui(Chief Scientific Officer)Rose Marino(Chief Medical Officer)Peter McWilliams(Chief Business Officer)Geoffrey Hird(Chief Technology Officer)
Co-investorsAdvent Life SciencesMission Bay CapitalMission BiocapitalRemiges Ventures, Inc.RiverVest Venture PartnersSanofi Ventures
Philips develops health technology and consumer products for patients, healthcare providers, and households, with an emphasis on durable, recyclable products.
Circular EconomyConsumerHealthtechMedical DevicesAmsterdam, NL
Co-investorsExcel Venture ManagementNew Enterprise Associates (NEA)
Bionano Genomics develops optical genome mapping (OGM) systems, software, and sample-preparation tools for detecting structural variants and chromosomal aberrations across cancer, genetic disease, reproductive health, and cell therapy applications.
BiotechHealthtechMedical Devices
Merck is a pharmaceutical company that researches, develops, and produces medicines and vaccines, with a focus on areas such as oncology and immunotherapy.
BiotechHealthtech
Eden Prairie, US
Bobak Azamian(Executive Officer, Director)Tony Vrba(Executive Officer)Kevin Hykes(Executive Officer, Director)Kirk Nielsen(Director)
Co-investorsNew Enterprise Associates (NEA)Versant Ventures
Metavention is developing a treatment that targets the sympathetic nervous system to disrupt overactive nerves believed to contribute to high blood pressure and other metabolic diseases.
BiotechHealthtechMedical Devices
Co-investorsVensana Capital
Pacira develops and commercializes non-opioid therapies for postsurgical, chronic, and musculoskeletal pain, and is advancing a gene therapy pipeline candidate.
BiotechHealthtech
San Jose, US
Robert M Abrams(Executive Officer, Director)Muscarella Thomas(Executive Officer)
BoardTimothy C. Mills(Director)Matt Jenusaitis(Director)
Regeneron is a biotechnology company that develops medicines ranging from biologics to genetic medicines to treat serious diseases across areas such as metabolic disease, ophthalmology, and rare disease.
BiotechHealthtechTarrytown, US
Co-investorsRidgeback CapitalvenBio PartnersWireframe Ventures
Sotera Wireless manufactures the ViSi Mobile System, a wearable patient monitoring platform that continuously tracks vital signs including blood pressure, oxygen saturation, heart rate, and ECG in general hospital care settings.
AI & Machine LearningHealthtechMedical Devices
Stereotaxis develops robotic systems for interventional medicine, focused on endovascular and cardiac procedures such as cardiac ablation.
HealthtechMedical DevicesRoboticsSaint Louis, US
David Fischel(Chairman & CEO)
HealthtechChapel Hill, US
Mehdi Paborji(Executive Officer, Director)Roger L. Flugel(Executive Officer, Director)Roger S. Flugel(Executive Officer, Director)
BoardNasser J. Kazeminy(Director)Fred A. Middleton(Director)Benjamin F. McGraw III(Executive Officer, Director)
TheraVida is a clinical-stage specialty pharmaceutical company developing combination drug therapies for patients with hyperhidrosis (excessive sweating).
BiotechMedical DevicesChapel Hill, US
Benjamin F. McGraw(CEO & Chairman)Rhonda Donahoe(CFO)Assad Kazeminy(VP, Business Development)
Merck is a pharmaceutical company focused on developing medicines and vaccines for patients globally, guided by a science-led innovation strategy.
BiotechHealthtechMedical DevicesRahway, US
Co-investorsAisling CapitalAtlas VentureHM Venture PartnersSPRINGROCK VENTURESThe Column Group
BiotechShoreview, US
Todd Berg(Executive Officer, Director)Brian Mower(Executive Officer)
BoardChris Grant(Director)Timothy Mills(Director)Charles Larsen(Director)James Thomas(Director)
BiotechSan Diego, US
Brittany Bradrick(Executive Officer)Anne Sandan(Executive Officer)Elizabeth Bui(Executive Officer)Steve White(Executive Officer)Howard Foyt(Executive Officer)Donald J. Elmer(Director)
Co-investorsBain Capital Life SciencesRA CapitalThe Vertical GroupRed Tree Venture
XOMA Royalty is a biotech royalty aggregator that acquires the economic rights to future milestone and royalty payments tied to partnered pre-commercial clinical candidates, providing sellers with non-dilutive, non-recourse funding.
BiotechFintech
Owen Hughes(Chief Executive Officer)Jeffrey Trigilio(Chief Financial Officer)Brad Sitko(Chief Investment Officer)Maricel Montano(Chief Legal Officer)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 11
IPOs and acquisitions across the tracked portfolioHCW BiologicsNASDAQ: HCWBBoston ScientificNYSE: BSXCalcimedicaNASDAQ: CALCStereotaxisNYSE: STXSActimisacq. by Boehringer IngelheimAderisacq. by Schwarz PharmaDepoTechacq. by SkyePharmaEndocyte NASDAQ: ECYT www.endocyte.comacq. by NovartisInfraReDxacq. by Nipro CorporationNaviscanacq. by CMR NaviscanSjmacq. by Abbott
Portfolio news
latest coverage across their companiesHCW Biologics · stocktitan.net · Aug 20, 2026
Stereotaxis · simplywall.st · Aug 13, 2026
Frequently asked questions
- How many investments has Sanderling Ventures made?
- Sanderling Ventures has 71 tracked investments, 7 of which have exited via acquisition or IPO.
- What stage does Sanderling Ventures invest at?
- Sanderling Ventures invests at the Seed, Series A, Late Stage stages.
- What is Sanderling Ventures's typical check size?
- Sanderling Ventures typically writes checks of $50K – $1M.
- What sectors does Sanderling Ventures focus on?
- Sanderling Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Sanderling Ventures located?
- Sanderling Ventures is headquartered in San Mateo, US.
- Who does Sanderling Ventures co-invest with?
- Sanderling Ventures most often shares deals with Aisling Capital, Oak Investment Partners, Remiges Ventures, Inc., among 42 tracked co-investors.
Images
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.
Khosla Ventures is a venture capital firm that invests in early-stage companies focused on technology, mobile, and clean energy sectors, including biotechnology applications. The firm provides capital and strategic support to entrepreneurs developing breakthrough technologies across multiple markets.